Click here to Register    
 
Clinical Dialogue & eCase Challenge spacer Ask The Experts
Shadow

MS-Leaders.org™ is an online educational resource for MS treating clinicians designed to provide cutting edge information and resources to help support patient care.  MS-Leaders.org provides a variety of engaging and clinically relevant educational platforms to deliver a breadth of content to meet the needs of busy clinicians:

Clinical Dialogues and eCase Challenges:  Clinical Dialogues are video-based moderated discussions featuring leading MS experts.  Clinical Dialogues are accompanied by an interactive eCase Challenge, which presents challenging case scenarios and supports the application of the education delivered in the Clinical Dialogue program into clinical practice.  Following each case, a video commentary provides key clinical pearls that summarize the most important aspects of the case.

Ask the Expert:  Ask the Expert provides MS-Leaders.org registrants with the opportunity to present their own clinical challenges to leading MS experts, and to review a growing library of archived questions and answers.  Responses to questions are sent directly to the registrant posing the question, thus providing a unique opportunity for MS treating clinicians to readily access leading MS experts.

We encourage you to register with MS-Leaders.org today and to take advantage of the many resources that this unique online educational site offers.

MS-Leaders.org™ is a trademark of Medical Logix, LLC.

© 2010 Medical Logix, LLC. All rights reserved.

About MS-Leaders

MS-Leaders.org™ is an online educational resource for MS treating clinicians designed to provide cutting edge information and resources to help support patient care.  MS-Leaders.org provides a variety of engaging and clinically relevant educational platforms to deliver a breadth of content to meet the needs of busy clinicians:

  •  Clinical Dialogues and eCase ChallengesClinical Dialogues are video-based moderated discussions featuring leading MS experts.  Clinical Dialogues are accompanied by an interactive eCase Challenge, which presents challenging case scenarios and supports the application of the education delivered in the Clinical Dialogue program into clinical practice.  Following each case, a video commentary provides key clinical pearls that summarize the most important aspects of the case.
     
  • Ask the Expert:  Ask the Expert provides MS-Leaders.org registrants with the opportunity to present their own clinical challenges to leading MS experts, and to review a growing library of archived questions and answers.  Responses to questions are sent directly to the registrant posing the question, thus providing a unique opportunity for MS treating clinicians to readily access leading MS experts.

    We encourage you to register with MS-Leaders.org today and to take advantage of the many resources that this unique online educational site offers.

MS-Leaders.org™ is a trademark of Medical Logix, LLC.

© 2010 Medical Logix, LLC. All rights reserved.

 

 
 

Multiple sclerosis (MS) is a chronic central nervous system (CNS) disease that is progressive and has no current cure. In the United States (U.S.), MS affects nearly one million patients. More than 10,000 are newly diagnosed with MS annually. Due to its effects on movement, sensation, vision, and other domains, MS can severely hinder a person’s ability to walk, cook, work, enjoy hobbies, and achieve life goals, leading to significant impact on quality of life. Similarly, in studies of health, physical functioning, and social functioning, patients with MS have worse ratings compared with those with other chronic diseases.

Medications such as immunomodulatory and immunosuppressive disease-modifying therapies (DMTs) can delay this damage and slow the resulting progressive phase, thus helping maintain quality of life. Similarly, these DMTs can reduce frequency of attacks or breakthrough disease activity in RRMS. However, a one-size-fits-all approach does not work when appropriately treating patients with MS. Within a given patient and treatment course, new MS symptoms may become unmasked, adverse events may emerge, or a medication may simply lose effectiveness. From here, clinicians are signaled that a change in medication course may be needed. To make an informed decision, clinicians need to understand the rationale behind medication choices and the risks and benefits of DMTs available.

The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category CreditsTM

Click here to view this program

 
MS-Leaders™ is a trademark of Medical Logix, LLC.
© 2010 Medical Logix, LLC. All rights reserved